Source: Future Medicine
The aim of this study was to assess the benefit of stem cell therapy in the treatment of mild to severe knee osteoarthritis.
A variety of regenerative therapies, including intraarticularly applied hemo-components and cell-based therapies are currently in clinical development and are, in part, in clinical use. Such therapies face several practical opportunities and challenges and could reduce the health care burden, in part by replacing traditional drug therapies and highly invasive surgical interventions with smarter and less invasive treatments.
The aim of this systematic review is to explore the current available knowledge about tendon disorders and orthobiologics derived by preclinical experiments to evaluate their role and efficacy in the different stages and conditions related to the tendon healing processes.
Source: Los Angeles Business Journal
Next month, a SpaceX rocket is set to carry an unusual payload to the International Space Station: a sample of stem cells to be cultivated as part of a Cedars-Sinai Medical Center research project to see if the cells can grow more rapidly and achieve better quality in space.
Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have turned to a silk protein, silk fibroin (SF), produced by the Bombyx mori silkworm as a biomaterial for tendon repair. The researchers report their method has yielded significant improvements in mesenchymal stem cells (MSCs) tendon regeneration.
Source: AZO Nano
An article published in the journal Biomaterials shows that CuS@MnO2 nanoparticles (NPs) synthesized with a short bacteriophage-selected mesenchymal stem cell (MSC) targeting peptide allowed the MSCs to take up these NPs. NP-modified MSCs produced greatly improved therapy of Rheumatoid Arthritis (RA) using stem cells.
A woman living with HIV in the United States may be the first female and third person to have been “cured” of HIV through stem cell transplants.